Long‐Term Endocrine Effects of Hematopoietic Stem Cell Transplantation in Children: A Reappraisal
Clinical Transplantation · 2026-03 · 40 (3)
DOI: 10.1111/ctr.70504 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, online erschienen am 18.03.2026. Verfasst von Dilek Gürlek Gökçebay und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology Bone Marrow Transplantation Unit, University of Health Sciences Ankara Bilkent City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Endocrine System Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Hematopoietic stem cell transplantation (HSCT) is widely used in both malignant and non‐malignant diseases in children. This study aimed to evaluate long‐term endocrine complications in pediatric HSCT survivors.
Methods
Children who underwent HSCT between April 2010 and October 2014 were retrospectively assessed. Data included demographics, growth and nutritional status, thyroid function, bone health, pubertal development, and gonadal function.
Results
Seventy‐five patients (45 males, 30 females; mean current age 18.8 ± 3.9 years) were included. The mean follow‐up duration after HSCT was 9.7 ± 1.2 years, and at least one endocrine disorder was identified in 40 patients (53.3%). At the last follow‐up, 23 patients (30.6%) were underweight, and 17 (18.6%) had short stature. Growth impairment was more frequent in patients with non‐malignant diseases. Hypothyroidism was observed in 6 patients (8%), and low bone mineral density (BMD)/osteoporosis in 17 (22.6%). Short stature, malnutrition, low BMD, and vitamin D deficiency were more prevalent among those who underwent HSCT at ≥10 years of age. Hypogonadism was detected in 12 females (40%) and 11 males (24%) and showed no association with age at HSCT, pubertal stage, primary diagnosis, or conditioning regimen.
Conclusions
These findings underscore the importance of long‐term endocrine surveillance in HSCT survivors, particularly in those transplanted at ≥10 years of age.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Hematology Bone Marrow Transplantation Unit, University of Health Sciences Ankara Bilkent City Hospital, Ankara, Turkey.
- Department of Pediatrics, University of Health Sciences Ankara Bilkent City Hospital, Ankara, Turkey.
- Department of Pediatric Hematology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
ORCID-Profile: Dilek Gürlek Gökçebay, Gamze Gürsoy, İkbal O K Bozkaya, Ozlem Arman Bilir, Namik Yasar Ozbek
Zitieren
APA
Gürlek Gökçebay, D., Gürsoy, G., Kanbur, M., O K Bozkaya, İ., Arman Bilir, O., & Ozbek, N. Y. (2026). Long‐Term Endocrine Effects of Hematopoietic Stem Cell Transplantation in Children: A Reappraisal. Clinical Transplantation, 40(3). https://doi.org/10.1111/ctr.70504
Vancouver
Gürlek Gökçebay D, Gürsoy G, Kanbur M, O K Bozkaya İ, Arman Bilir O, Ozbek NY. Long‐Term Endocrine Effects of Hematopoietic Stem Cell Transplantation in Children: A Reappraisal. Clinical Transplantation. 2026;40(3). doi:10.1111/ctr.70504
BibTeX
@article{GrlekGkebay2026,
author = {Gürlek Gökçebay, Dilek and Gürsoy, Gamze and Kanbur, Mehtap and O K Bozkaya, İkbal and Arman Bilir, Ozlem and Ozbek, Namik Yasar},
title = {Long‐Term Endocrine Effects of Hematopoietic Stem Cell Transplantation in Children: A Reappraisal},
journal = {Clinical Transplantation},
year = {2026},
volume = {40},
number = {3},
doi = {10.1111/ctr.70504}
}
EUVIMED